Andy Green and Helen Silver-MacMahon to speak on time management and leadership.
The BSAVA has announced a series of time management and leadership modules for veterinary nurses at its upcoming congress.
Led by Andy Green, people director at Pennard Vets in Kent, and RVN, Helen Silver-MacMahon, VN research and development director at VetLed, the sessions will explore how veterinary nurses are uniquely placed to ensure a practice runs smoothly and efficiently.
Depending on the circumstances, harnessing the full potential of the practice team can require structural changes, a shift in organisational culture, and investing in people. Such topics will be explored by Andy and Helen throughout the congress, with a particular focus on the central role of the veterinary nurse.
As Andy explains: “High-functioning practices, revolve around the nurses. Naturally, they are a communication hub. And let’s face it, if a vet wants to do something outside of the consult room, they will need a nurse. It makes sense to recognise the essential role they play and develop a nurse-centric structure.”
During their talks, Helen and Andy will explore how to help nurses upskill and become confident in working at the highest possible level and the benefits that come from this, such as mitigating the effects of recruitment and retention issues.
Helen said: “Where nurses’ contribution and potential are recognised, and the hierarchy is shallowed, they make incredible leaders. At BSAVA Congress 2023, I’ll be speaking about delegation.
“As leaders, we feel we have to ‘own’ tasks and that inevitably means doing it ourselves. But that’s not always the best option. It can leave leaders feeling overwhelmed. Whereas delegating tasks can empower others, build resilience within the team and help with retention.”
The talks take place at BSAVA Congress 2023, Manchester Central, on 23rd-25th March 2023. Discover the complete programme at bsavaevents.com
Image (C) BSAVA.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
